Information to Go

Your health is important to us. We know having quality medicines on-hand and quality information in-hand is an important combination for your health regiment.

We currently offer two free innovative mobile applications that can help you get more out of your experience with Mylan products.

MyEpiPlan: Important Information about Severe Allergies and the EpiPen® (epinephrine) Auto-Injector

This mobile app for Apple and Android smartphones allows patients and caregivers of children with life-threatening-allergies to create allergen profiles that describe their condition. This profile can then be shared with friends, teachers, babysitters and other caregivers who may be responsible to help avoid the life-threatening allergic conditions.

You can read about severe allergies and get food tips. After registering your EpiPen Auto-Injectors in the app, you can you set expiration reminders and using your phone’s GPS, geo-mark the places where you store spare EpiPen® two-paks. REMEMBER, ALWAYS CARRY AN EPIPEN® AUTO-INJECTOR 2-PAK WITH YOU AT ALL TIMES.

Generic Brand Reference Guide: Information on More Than 1,300 Products

Created with physicians, pharmacists and other medical professionals in mind, the Generic Brand Reference Guide, or GBR®, app is an easy-to-use generic/brand name reference guide. It’s an invaluable resource designed to help users quickly cross-reference generic names and brand name products.

The GBR also features full-color identification guides to Mylan’s Institutional, Pharmaceutical and Specialty portfolios—all the products we market in the United States. Each entry includes information on dosage strength, package size and NDC numbers.


We design our apps the same way we design everything we make—with people and their health in mind. After all, while our mission is providing 7 billion people access to high quality medicine, we also make sure that everyone has the information they need to take that medicine with confidence.

EpiPen® (epinephrine) 0.3 mg and EpiPen Jr® (epinephrine) 0.15 mg Auto-Injectors are for the emergency treatment of life-threatening allergic reactions (anaphylaxis) caused by allergens, exercise, or unknown triggers; and for people who are at increased risk for these reactions. EpiPen and EpiPen Jr are intended for immediate self administration as emergency supportive therapy only. Seek immediate emergency medical treatment after use.

Important Safety Information 
EpiPen Auto-Injectors contain a single dose of epinephrine, which you inject into your outer thigh. DO NOT INJECT INTO YOUR VEIN, BUTTOCK, FINGERS, TOES, HANDS OR FEET. In case of accidental injection, please seek immediate medical treatment. Epinephrine should be used with caution if you have heart disease or are taking certain medicines that can cause heart-related (cardiac) symptoms.

Tell your doctor if you have certain medical conditions such as asthma, depression, thyroid disease, Parkinson’s disease, diabetes, high blood pressure and heart disease, have any other medical conditions, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Be sure to also tell your doctor all the medicines you take, especially medicines for asthma. If you have certain medical conditions, or take certain medicines, your condition may get worse or you may have longer lasting side effects when you take the EpiPen or EpiPen Jr Auto-Injector.

The most common side effects may include increase in heart rate, stronger or irregular heartbeat, sweating, nausea and vomiting, difficulty breathing, paleness, dizziness, weakness or shakiness, headache, apprehension, nervousness or anxiety. These side effects usually go away quickly, especially if you rest.

Talk to your healthcare professional to see if EpiPen or EpiPen Jr Auto-Injector is right for you.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

For additional information please contact us at 800-395-3376.

EpiPen®, EpiPen Jr®, are registered trademarks of Mylan Inc. licensed exclusively to its wholly-owned subsidiary, Mylan Specialty L.P.

Please see full Prescribing Information
Please see the Patient Information.